Oshima Yasuko, Moriyama Takahito, Itabashi Mitsuyo, Takei Takashi, Nitta Kosaku
Department of Medicine, Kidney Center, Tokyo Women's Medical University, Kawada-cho 8-1, Shinjuku-ku, Tokyo, 162-8666, Japan.
Int Urol Nephrol. 2015 Jan;47(1):137-45. doi: 10.1007/s11255-014-0872-1. Epub 2014 Nov 12.
The susceptible age for IgA nephropathy (IgAN) is <30 years. However, IgAN sometimes develops in people aged >60 years, and its characteristics remain unknown.
We divided 600 IgAN patients into three groups: advanced-age group (AAG, n=31, ≥60 years); middle-aged group (MAG, n=162, 40-59 years); and young-aged group (YAG, n=407, 20-39 years). We analyzed clinical and histological background, renal outcome, and risk of progression.
In the AAG, mean arterial pressure (MAP) and the number of hypertensive patients were significantly higher than in the YAG. Total protein, serum albumin, and estimated glomerular filtration rate were significantly lower, and blood urea nitrogen, proteinuria, and N-acetyl-β-D-glucosaminidase were significantly higher in the AAG than in MAG and YAG. In histological findings, interstitial fibrosis/tubular atrophy by Oxford classification and arteriosclerosis were more severe in the AAG than the in YAG. Renal survival rate analyzed by Kaplan-Meier method was significantly lower in the AAG (22.9%/19 years in the AAG vs. 69.2 and 84.9%/20 years in the MAG and YAG, p<0.0001). The patients who progressed to end-stage renal disease (ESRD) in the AAG had higher MAP and more severe proteinuria compared with the patients who did not progress to ESRD in the AAG.
The characteristics of IgAN in advanced-age were lower renal function, high levels of proteinuria, severe interstitial change, and arteriolosclerosis caused by glomerulopathy and concomitant diseases, such as hypertension, dyslipidemia, and hyperuricemia. Prognosis was poor, and >70% developed ESRD within 20 years.
IgA 肾病(IgAN)的易感年龄小于 30 岁。然而,IgAN 有时也会在 60 岁以上人群中发病,其特征尚不清楚。
我们将 600 例 IgAN 患者分为三组:老年组(AAG,n = 31,≥60 岁);中年组(MAG,n = 162,40 - 59 岁);青年组(YAG,n = 407,20 - 39 岁)。我们分析了临床和组织学背景、肾脏结局以及疾病进展风险。
在老年组中,平均动脉压(MAP)和高血压患者数量显著高于青年组。老年组的总蛋白、血清白蛋白和估计肾小球滤过率显著更低,而血尿素氮、蛋白尿和 N - 乙酰 - β - D - 氨基葡萄糖苷酶显著高于中年组和青年组。在组织学检查结果中,牛津分类法中的间质纤维化/肾小管萎缩和动脉硬化在老年组比青年组更严重。采用 Kaplan - Meier 法分析的肾脏生存率在老年组显著更低(老年组为 22.9%/19 年,中年组和青年组分别为 69.2%和 84.9%/20 年,p < 0.0001)。与未进展至终末期肾病(ESRD)的老年组患者相比,进展至 ESRD 的老年组患者 MAP 更高且蛋白尿更严重。
老年 IgAN 的特征为肾功能较低、蛋白尿水平高、间质改变严重以及由肾小球病和伴随疾病(如高血压、血脂异常和高尿酸血症)引起的小动脉硬化。预后较差,超过 70%的患者在 20 年内发展为 ESRD。